glp 1 drugs pill form The FDA has approved the first version of GLP-1 drugs. Novo Nordisk says participants who took the Wegovy pill in clinical trials lost an average of 16.6% of their body weight US regulators approve GLP-1 pill

Abstract Purpose of Review Hypertension is the leading modifiable risk factor for cardiovascular disease

This has sparked interest in newer metabolic therapies like GLP1 receptor agonists, especially in the context of managing PCOS-related metabolic issues

171 Additionally, small molecule drugs may have better tissue permeability, longer half-lives in the body, and lower production costs

Januvia [package insert]

What this means to me: This isnt just innovationits a shift in how we approach chronic diseases like diabetes and obesity

The reason they are interesting for PMOS is simple: many women with PMOS have insulin resistance